rs62408925 — NCK1

NCK1 rs62408925 — A Regulatory Signal That Turns Up Kidney Filter Stress

The kidney's glomerular filter depends on an intricate architecture of specialized cells called podocytes¹¹ podocytes
Podocytes: highly differentiated epithelial cells that wrap around glomerular capillaries with interdigitating foot processes connected by slit diaphragms, forming the final barrier against protein leakage into urine. rs62408925 sits in the intergenic region at chromosome 3q22.3, in the vicinity of NCK1 — a molecular adaptor that physically connects the podocyte's slit diaphragm protein nephrin to its actin cytoskeleton. Genetic variation at this locus has been linked to elevated diabetic nephropathy (DN) risk, the most common serious complication of type 1 diabetes and a leading cause of end-stage renal disease worldwide.

The Mechanism

rs62408925 is not itself a coding variant — it sits in an intergenic region and does not change any amino acid sequence. It marks one boundary of an 11 kilobase segment that contains three highly conserved regulatory elements, and it is in strong linkage disequilibrium²² strong linkage disequilibrium
Linkage disequilibrium (LD): the non-random co-inheritance of nearby alleles on the same chromosome. r²=0.95 means the two variants are almost always co-inherited — knowing one nearly perfectly predicts the other (r²=0.95) with rs1866813, the functional variant at this locus.

Mechanistic studies³³ Mechanistic studies
He B et al. A remote cis-acting variant at 3q links glomerular NCK1 to diabetic nephropathy. PLoS One, 2013 show that rs1866813 operates as a remote cis-regulatory element approximately 70 kb upstream of the NCK1 transcription start site. The risk allele drives higher NCK1 expression specifically in glomerular tissue. NCK1 encodes an adaptor protein with SH2 and SH3 domains that binds phosphorylated nephrin at the slit diaphragm and recruits actin polymerization machinery — it is the molecular bridge⁴⁴ it is the molecular bridge
Jones N et al. Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes. Nature, 2006 between the filtration barrier's membrane architecture and the cytoskeletal scaffolding that holds foot processes in shape.

Under hyperglycemia, podocytes are already under metabolic and oxidative stress. Elevated NCK1 expression may dysregulate the tight balance of nephrin-actin signaling needed to maintain foot process architecture. Adult podocyte-specific NCK deletion in mice rapidly produced proteinuria, glomerulosclerosis, and foot process effacement⁵⁵ rapidly produced proteinuria, glomerulosclerosis, and foot process effacement
Jones N et al. Nck proteins maintain the adult glomerular filtration barrier. J Am Soc Nephrol, 2009 within 1–2 weeks — demonstrating that NCK dosage dysregulation in either direction can compromise the filtration barrier.

The Evidence

The initial genetic association came from a multistage case-control study⁶⁶ multistage case-control study
He B et al. Association of genetic variants at 3q22 with nephropathy in patients with type 1 diabetes mellitus. AJHG, 2009 of 1,822 diabetic nephropathy cases and 1,874 controls from Finland, Iceland, and the British Isles. rs1866813 (r²=0.95 with rs62408925) showed a combined odds ratio of 1.33 for DN, with the Finnish replication cohort yielding OR=1.38 (95% CI 1.18–1.62, p=4.7×10⁻⁵). The association was codominant, meaning each risk allele copy incrementally increased risk.

The 2013 mechanistic paper provided supporting biological plausibility — allele-specific luciferase reporter assays in lymphocytes and transgenic zebrafish with podocyte-specific GFP reporters confirmed differential expression driven by the two alleles. This molecular evidence substantially strengthens the interpretation beyond a statistical association alone.

The evidence level is rated moderate: the original association was replicated within the same 2009 study across populations, and mechanistic validation exists, but independent large-scale replication by separate groups is not established in the literature. The locus has not appeared in the largest diabetic nephropathy GWAS meta-analyses to date, possibly reflecting heterogeneity across type 1 versus type 2 diabetes cohorts or statistical power constraints.

Practical Actions

For carriers of the CT or TT genotype with type 1 diabetes, the primary actionable implication is earlier and more frequent kidney function monitoring. Diabetic nephropathy progresses through stages detectable years before clinical kidney impairment — microalbuminuria (UACR 30–300 mg/g) is the earliest measurable sign. Early detection enables RAAS blockade (ACE inhibitors or ARBs) that substantially slows DN progression.

For the roughly 86% of people who carry the common CC genotype, standard nephropathy screening guidelines for type 1 diabetes apply (annual UACR from 5 years after diagnosis).

For people without type 1 diabetes, this locus has no identified clinical relevance — the association is specific to the diabetic hyperglycemic milieu that places podocyte stress on NCK1 dysregulation.

Interactions

The neighboring gene IL20RB at 3q22.3 encodes the IL-20 receptor beta subunit, which participates in cytokine signaling relevant to kidney inflammation. IL20RB protein has been detected in biopsies from diabetic nephropathy, IgA nephropathy, and lupus nephritis patients, raising the possibility that the 3q22 locus contains multiple independent regulatory signals. The LD structure of the region means rs62408925 and rs1866813 may co-tag both NCK1 and IL20RB regulatory elements, though this has not been mechanistically resolved.

Diabetic nephropathy risk is substantially modified by glycemic control — the hyperglycemic environment is the necessary cofactor for NCK1-related podocyte injury to manifest. Variants affecting insulin secretion (TCF7L2 rs7903146) or insulin sensitivity (PPARG rs1801282) are independent DN risk modifiers through glucose control pathways.